174 related articles for article (PubMed ID: 32861229)
1. Affordability of Medication Therapy in Diabetic Patients: A Scenario-Based Assessment in Iran's Health System Context.
Zarei L; Peymani P; Moradi N; Kheirandish M; Mirjalili M; Zare M
Int J Health Policy Manag; 2022 Apr; 11(4):443-452. PubMed ID: 32861229
[TBL] [Abstract][Full Text] [Related]
2. Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines.
Zarei L; Karimzadeh I; Moradi N; Peymani P; Asadi S; Babar ZU
Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32151039
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country.
Fathi M; Moradi N; Yousefi N; Peiravian F; Shobeiri N
BMC Pulm Med; 2023 Nov; 23(1):429. PubMed ID: 37925396
[TBL] [Abstract][Full Text] [Related]
4. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
5. Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.
Sarayani A; Rashidian A; Gholami K
BMJ Open; 2014 Oct; 4(10):e005859. PubMed ID: 25324322
[TBL] [Abstract][Full Text] [Related]
6. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
[TBL] [Abstract][Full Text] [Related]
7. Availability and affordability of children essential medicines in health facilities of southern nations, nationalities, and people region, Ethiopia: key determinants for access.
Tadesse T; Abuye H; Tilahun G
BMC Public Health; 2021 Apr; 21(1):714. PubMed ID: 33849513
[TBL] [Abstract][Full Text] [Related]
8. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
9. Availability, affordability and price components of insulin products in different-level hospital pharmacies: Evidence from two cross-sectional surveys in Nanjing, China.
Wang L; Dai L; Liu H; Dai H; Li X; Ge W
PLoS One; 2021; 16(8):e0255742. PubMed ID: 34383816
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
11. The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries.
Babar ZU; Ramzan S; El-Dahiyat F; Tachmazidis I; Adebisi A; Hasan SS
Front Pharmacol; 2019; 10():1375. PubMed ID: 31824316
[No Abstract] [Full Text] [Related]
12. Affordability of essential medicines: The case of fluoride toothpaste in 78 countries.
Gkekas A; Varenne B; Stauf N; Benzian H; Listl S
PLoS One; 2022; 17(10):e0275111. PubMed ID: 36260605
[TBL] [Abstract][Full Text] [Related]
13. Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018.
Kibira D; Ssebagereka A; van den Ham HA; Opigo J; Katamba H; Seru M; Reed T; Leufkens HG; Mantel-Teeuwisse AK
Malar J; 2021 Mar; 20(1):142. PubMed ID: 33691704
[TBL] [Abstract][Full Text] [Related]
14. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa.
Mattila PO; Babar ZU; Suleman F
BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693
[TBL] [Abstract][Full Text] [Related]
15. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.
Sharma A; Kaplan WA; Satheesh G; Poudyal IP; Gyawali P; Neupane D; Bhandari PM; Malla M; Sapkota S; Mishra SR
Glob Heart; 2021 May; 16(1):38. PubMed ID: 34040951
[TBL] [Abstract][Full Text] [Related]
16. Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran.
Zarei L; Moradi N; Peiravian F; Hatami-Mazinani N; Mahi-Birjand M; Arabloo J; Babar ZU
Int J Equity Health; 2022 Dec; 21(1):188. PubMed ID: 36581933
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan.
Bibi M; Haq NU; Kareem A; Ullah H; Baloch N; Rehman G; Nasim A
Int J Public Health; 2022; 67():1604375. PubMed ID: 35872706
[No Abstract] [Full Text] [Related]
18. Availability, pricing and affordability of selected medicines for noncommunicable diseases.
Heidari E; Varmaghani M; Abdollahiasl A
East Mediterr Health J; 2019 Oct; 25(7):473-480. PubMed ID: 31612979
[TBL] [Abstract][Full Text] [Related]
19. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
20. Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
